Arkolith/Insider Trading/RPHM/Form 4

Flesher Gregory J.

President and CEO, DirectorReneo Pharmaceuticals, Inc. (RPHM) · full profile →Form 4 · filed Dec 14, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 10, 2021Grant(A)100K—$0110K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 10, 2021Grant(A)200K—$0200K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-069443) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML